Task: Answer the multiple-choice question.
Question: Which drug exhibits a -13.532\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) Cc1sc(NC(=O)c2cccc([N+](=O)[O-])c2)c(C(N)=O)c1-c1ccc(C(C)(C)C)cc1
(b) COc1cc(COCC(O)CN2CCN(Cc3ccc4c(c3)OCO4)CC2)cc(OC)c1OC.Cl
(c) Cc1nc2ncnn2c(C)c1CCC(=O)NCc1ccc2c(c1)OCO2
Answer: c. Cc1nc2ncnn2c(C)c1CCC(=O)NCc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2ncnn2c(C)c1CCC(=O)NCc1ccc2c(c1)OCO2
Cc1nc2ncnn2c(C)c1CCC(=O)NCc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-ylmethyl)-3-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)propanamide